Cargando…
Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma
Efavirenz is an anti-viral agent of non-nucleoside reverse transcriptase inhibitor category used as a part of highly active retroviral therapy for the treatment of infections of human immune deficiency virus type-1. A simple, sensitive and rapid reversed—phase high performance liquid chromatographic...
Autores principales: | Gupta, Shweta, Kesarla, Rajesh, Chotai, Narendra, Omri, Abdelwahab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432066/ https://www.ncbi.nlm.nih.gov/pubmed/28505168 http://dx.doi.org/10.1371/journal.pone.0174777 |
Ejemplares similares
-
Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability
por: Gupta, Shweta, et al.
Publicado: (2017) -
Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
por: Gupta, Shweta, et al.
Publicado: (2013) -
RP-HPLC method for simultaneous estimation of tenofovir disoproxil fumarate, lamivudine, and efavirenz in combined tablet dosage form
por: Bhavsar, Dhara S., et al.
Publicado: (2012) -
Retention Modelling of Phenoxy Acid Herbicides in Reversed-Phase HPLC under Gradient Elution
por: Biancolillo, Alessandra, et al.
Publicado: (2020) -
Development and validation of RP-HPLC method for estimation of eplerenone in spiked human plasma
por: Gide, Paraag, et al.
Publicado: (2012)